NGS Genetic Comprehensive Cancer Panel consists of testing for more than 100 genes associated with genetic cancer risk predispositions.  Our panel looks for genes associated with in increased risk of developing cancer in an individual or their family.  Testing strategy may involve testing other family members or affected family members first

We use an advanced AI-driven bioinformatics pipeline that includes searches across 50+ databases including a 750000-person genetic disease database.